MARCAIN

This brand name is authorized in Hong Kong SAR China, Ireland, Japan, Lithuania, Malta, New Zealand, UK.

Active ingredients

The drug MARCAIN contains one active pharmaceutical ingredient (API):

1	Bupivacaine UNII 7TQO7W3VT8 - BUPIVACAINE HYDROCHLORIDE
	Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.
	Read more about Bupivacaine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MARCAIN POLYAMP STERIPACK Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
MARCAIN HEAVY Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01BB01	Bupivacaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	209408, 209410, 44753
HK	Department of Health Drug Office	35572, 35573, 42437
JP	医薬品医療機器総合機構	1214403A1026, 1214403A2022, 1214403A3029, 1214403A4025, 1214403A5021
LT	Valstybinė vaistų kontrolės tarnyba	1087821, 1088348, 1090655
MT	Medicines Authority	MA955/01101
NZ	Medicines and Medical Devices Safety Authority	1101, 1108, 1110, 1113